Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia
Closed
Phase 3
This trial is for people whose acute myeloid leukaemia (AML) has come back or continued to grow following their first or second treatment.
Recruitment start: 1 September 2016
Recruitment end: 10 January 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Steve Knapper
Roche
Last reviewed: 21 Jan 2020
CRUK internal database number: 14271